Protein-bound paclitaxel
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
 |
This article or section is in need of attention from an expert on the subject. WikiProject Pharmacology may be able to help recruit one. |
Protein-bound paclitaxel is a mitotic inhibitor drug used in the treatment of breast cancer. It is commonly used to treat cancers that have spread or returned within six months after chemotherapy.[1]
It is sold in the United States under the tradename Abraxane.[1]
See also
References
External links
